25,243.902
0.004 BRL
1.04 B BRL
9.14 B BRL
About Exelixis, Inc.
Sector
CEO
Michael M. Morrissey
Headquarters
Alameda
Website
Founded
1994
ISIN
BRE2XEBDR001
FIGI
BBG014XJH5R3
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where E2XE34 is featured.